SCHEDULE: Churchill Capital X Announces ColdQuanta Merger, $126.5M PIPE

Churchill Capital Corp X has entered into a definitive merger agreement with ColdQuanta, Inc., supported by a $126.5 million PIPE investment and new governance agreements.

Summary

• Churchill Capital Corp X (the "Issuer") has entered into a definitive Agreement and Plan of Merger and Reorganization (the "Merger Agreement") with ColdQuanta, Inc. (the "Company").
• The transaction involves a two-step merger where ColdQuanta will become a wholly-owned subsidiary of Churchill.
• The merger is subject to shareholder approvals from both the Issuer and the Company, as well as other closing conditions.
• In connection with the merger, Churchill entered into Subscription Agreements with PIPE Investors for a $126,547,600 private investment in public equity (PIPE) at $10.00 per share.
• The Sponsor and Insiders have agreed to vote in favor of the merger and related proposals, and not to redeem their shares.
• 1,500,000 of the Sponsor's Class B Shares will unvest at closing and revest if the Domesticated SPAC Common Stock VWAP reaches $12.00 for 15 trading days within 180 days post-closing, or upon a change of control at $12.00 per share, with forfeiture if not achieved within five years.
• An Advisory Agreement was established with M. Klein & Company, an affiliate of Michael Klein, for financial advisory and strategic consulting services, with a fixed quarterly retainer of $250,000.

Sentiment

Score: 7

Explanation: The filing announces a definitive merger agreement and a substantial PIPE investment, which are positive steps for a SPAC. The commitment from the sponsor and insiders is also a good sign. However, the vesting conditions for sponsor shares and the related-party advisory agreement introduce minor complexities.

Positives

• Securing a definitive merger agreement with ColdQuanta, indicating progress towards a business combination.
• Successful arrangement of a $126.5 million PIPE investment at $10.00 per share, providing capital for the combined entity.
• Sponsor and Insiders committing to vote in favor of the merger and not to redeem shares, signaling strong internal support.

Negatives

• 1,500,000 Sponsor shares are subject to a vesting condition tied to a $12.00 VWAP, which could lead to forfeiture if not met within five years, potentially diluting the sponsor's ultimate stake.
• The Advisory Agreement with an affiliate of Michael Klein, the CEO and Director, could raise questions about potential conflicts of interest, despite being disclosed.

Risks

• The proposed mergers are subject to the receipt of required approvals by the shareholders of the Issuer and the Company.
• Consummation of the mergers is contingent upon the satisfaction or waiver of certain other closing conditions set forth in the Merger Agreement.
• The PIPE Investment is conditioned on all conditions set forth in the Merger Agreement being satisfied or waived, and other customary closing conditions.
• Sponsor Shares are subject to forfeiture if the $12.00 VWAP vesting condition is not achieved within five years of the Closing.
• The Resale Registration Statement for Reg Rights Holders and the shelf registration for PIPE Shares must be filed and become effective within specified timeframes, subject to SEC review.

Future Outlook

The Issuer expects to consummate the proposed mergers with ColdQuanta following the receipt of required shareholder approvals and the satisfaction or waiver of certain closing conditions. Post-closing, the Domesticated SPAC will file registration statements for the resale of securities held by Reg Rights Holders and PIPE Investors within specified timeframes.

Management Comments

• Michael Klein disclaims any ownership of securities reported herein other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

Industry Context

This filing represents a significant step in the de-SPAC process for Churchill Capital Corp X, a special purpose acquisition company. The merger with ColdQuanta, a company in the quantum technology sector, aligns with the broader trend of SPACs seeking to identify and merge with private operating companies to bring them public. The PIPE investment is a common feature in SPAC transactions, providing additional capital and validating the valuation.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess the transaction against global benchmarks.
• The PIPE investment at $10.00 per share is a standard price for SPAC PIPE transactions, often reflecting the trust account value.
• The $12.00 VWAP vesting condition for sponsor shares is a common incentive structure seen in many SPAC deals, aligning sponsor interests with long-term shareholder value creation.

Corporate Governance

Related Party Transactions

• An Advisory Agreement was entered into between Churchill Capital Corp X and M. Klein & Company, through its affiliate, The Klein Group, LLC, effective upon the Closing of the Mergers. M. Klein & Company is affiliated with Michael Klein, the Chief Executive Officer and Director of the Issuer. The agreement provides for a fixed cash retainer fee of $250,000 per quarter for financial advisory, strategic consulting, and business development services.

Stakeholder Impact

• Shareholders: Will vote on the merger, and their shares will convert into Domesticated SPAC Common Stock. New transfer restrictions apply to certain shares. The PIPE investment provides capital, potentially reducing future dilution.
• PIPE Investors: Will acquire Domesticated SPAC Common Stock at $10.00 per share, subject to the merger closing.
• Sponsor/Insiders: Have committed to support the merger and face vesting conditions for a portion of their shares, aligning their interests with the company's performance.
• ColdQuanta Shareholders: Will become New Holders in the Domesticated SPAC, subject to transfer restrictions.
• Management (Michael Klein): Continues to play a significant role, with his affiliate receiving an advisory fee.

Next Steps

• Obtain required approvals from shareholders of Churchill Capital Corp X and ColdQuanta, Inc.
• Satisfy or waive other closing conditions set forth in the Merger Agreement.
• Consummate the Mergers and the PIPE Investment.
• File a resale registration statement for Reg Rights Holders within 30 business days after Closing.
• Cause the resale registration statement to become effective within 105 (or 165) calendar days after filing.
• File a shelf registration statement for the resale of PIPE Shares within 30 days after the consummation of the Transactions.
• Cause the PIPE shelf registration statement to become effective within 90 (or 150) days after the closing of the PIPE Investment.

Key Dates

Recommendation

The announcement of a definitive merger agreement with ColdQuanta and a substantial PIPE investment are positive developments for Churchill Capital Corp X, indicating progress towards a successful de-SPAC transaction. The commitment from the sponsor and insiders to vote in favor and not redeem shares provides a strong signal of internal support. However, the transaction is still subject to shareholder approvals and closing conditions, and the vesting structure for sponsor shares introduces a performance-based element. Given these factors, a 'hold' recommendation is appropriate as investors await the finalization of the merger and further details on the combined entity's prospects.

Keywords

Churchill Capital Corp X, ColdQuanta, SPAC, Merger, Business Combination, PIPE Investment, Schedule 13D, Michael Klein, Registration Rights, Sponsor Agreement, Advisory Agreement, De-SPAC